During the past decade, Clayton Eye Center conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 16 clinical trials were completed, i.e. on average, 106.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 11 clinical trials were completed. i.e. 550% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clayton Eye Center" #1 sponsor was "ForSight Vision5, Inc." with 4 trials, followed by "Aerie Pharmaceuticals" with 3 trials sponsored, "Allergan" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Johnson & Johnson Vision Care, Inc." with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clayton Eye Center" #1 collaborator was "Carl Zeiss Meditec, Inc." with 1 trials as a collaborator, "Optovue" with 1 trials as a collaborator and "ThromboGenics" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Clayton Eye Center" are "Ocular Hypertension" (9 trials), "Open Angle Glaucoma" (4 trials), "Primary Open-Angle Glaucoma" (4 trials), "Presbyopia" (3 trials) and "Dry Eye Syndromes" (2 trials). Many other conditions were trialed in "Clayton Eye Center" in a lesser frequency.

Most popular intervention types in "Clayton Eye Center" are "Drug" (18 trials), "Device" (6 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bimatoprost" (4 trials), "AGN-190584 ophthalmic solution" (2 trials), "AGN-199201 ophthalmic solution" (2 trials), "Placebo" (2 trials) and "Placebo Eye Drops" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clayton Eye Center" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Clayton Eye Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Clayton Eye Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clayton Eye Center, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".